SUNY Downstate Medical Center
450 Clarkson Avenue
Room A2-523 (cardiac cath lab)
Brooklyn, NY 11203-2098
Cell: 917-885-8854
more contact information
News and Media
Brooklyn Independant Television - Brooklyn Community Access Television Door to Balloon: Saving Hearts at SUNY Downstate (Aired: May 06, 2008)
The Doctor's Channel (May 2009)
Understanding the Fractional Flow Reserve
A New Tool to Understand Coronary Artery Disease
Theheart.org
In October 2006 Dr. Marmur was quoted on the theheart.org regarding the benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during PCI. His article on this subject appeared in Am Heart J. 2006.
In January 2006 Dr. Marmur's comments regarding the catheterization procedure being used to repair a hole in
Israeli Prime Minister
Arial Sharon's heart was carried in several major U.S. newspapers and media websites :
Dr. Jonathan Marmur, head of interventional cardiology at SUNY Downstate Medical Center in New York, said the procedure is "state of the art and cutting edge."
"The prognosis is excellent. For the most part, experience with these devices has been excellent. There's a low complication rate, high success rate and low stroke rate after implantation," he said.
Possible complications include the device moving from its intended position and slipping into the heart or bloodstream, or the device could erode or potentially perforate the heart, Dr. Marmur said. But he said the chance of either complication is "very small."
ABC News, AP Wire, Associated Press, The New York Times, The Boston Globe, Arizona Daily Sun, Press of Atlantic City, Daily Comet, Findlaw, GladStone Times (Alabama), Herald Sun, Herald Tribune, Herald-Zeitung, Inside Bay Area, Isreal Insider, Sarasota Herald, Times Argus (Vermont), Tuscaloosa News, WTOP
New York Times – Gene Therapy
In 1998, The New York Times carried Dr. Marmur's comments about Dr. Jeffrey Isner's coronary gene therapy research, as reported in Circulation , and a description of Dr. Marmur's own gene therapy research.
Nevertheless Dr. Isner's report "is very compelling," said Dr. Jonathan D. Marmur, a cardiologist at Mount Sinai.
"The benefit reported is pretty convincing," Dr. Marmur said, "and requires confirmation with control studies."
Dr. Marmur and some other experts expressed optimism that these or similar treatments might one day be administered through less invasive procedures than chest surgery.
...
Dr. Marmur, of Mount Sinai, is conducting a study testing two forms of therapy. One is a version of vegF made by Genentech Inc., a subsidiary of Roche Holding Ltd. The other is FGF-4 that has been inserted into an adenovirus, a cold virus; it is made by Berlex Laboratories of Wayne, N.J.
The study, which includes participants who will receive a placebo as controls, is also being conducted at William Beaumont Hospital in Royal Oak, Mich.; Duke University in Durham, N.C.; Johns Hopkins Hospital in Baltimore; the Mayo Clinic in Rochester, Minn.; the University of Michigan; the University of Minnesota in Minneapolis; the Minnesota Heart Clinic in Edina, Minn.; the University of Pittsburgh; the University of Vermont in Burlington; Washington Hospital Center in the District of Columbia; the University of Washington in Seattle, and the V.A. Hospital in San Diego.
Dr. Marmur said it had taken three months of discussion with Mount Sinai's ethics committee to win approval for the study because of concern that participants in the control group would be undergoing catheterization without receiving any FGF-4 or vegF.
Journal Editorials
Adiponectin and myocardial infarction: a paradox or a paradigm? EHJ 2006
“Bolus-only” glycoprotein IIb/IIIb inhibitor use for elective percutaneous coronary intervention: maybe less is more? AHJ 2006
Reputation
“… Dr. Marmur is an outstanding interventional cardiologist, an excellent teacher and role model and a
committed
academician. …”
Barry S. Coller M.D.
The Rockefeller University
“… Dr. Marmur has published extensively in the area of thrombosis and percutancous intervention in high impact journals. He has also gained respect for being extraordinarily knowledgeable in this field and a national reputation. …”
Magnus Ohman, M.D., F.A.C.C.
UNC School of Medicine
“… Dr. Marmur is a true expert in this field and has authored a number of important publications. His work on vascular biology is exceptionally well regarded …”
Eric J. Topol, M.D
Cleveland Clinic Lerner
College of Medicine
Pdfs for the full letters above are available upon written request.
